Sierra Oncology – $29.5 Million Shelf-Takedown

San Diego – February 23, 2017 – Cooley advised the underwriters on Sierra Oncology’s $29.5 million shelf-takedown offering of 21,847,636 shares of common stock. The underwriters maintain a 30-day option to purchase up to 577,364 additional shares.

Jefferies acted as sole book-running manager for the offering. Wedbush PacGrow and SunTrust Robinson Humphrey acted as co-managers for the offering.

Sierra Oncology, which trades on The NASDAQ Global Market as “SRRA,” is a clinical-stage drug development company advancing targeted therapeutics for the treatment of patients with cancer.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Charlie Kim Partner, San Diego
David Peinsipp Partner, San Francisco
Div Gupta Partner, New York
Kristin VanderPas Partner, San Francisco
Denny Won Associate, San Diego
Natasha Leskovsek Partner, Washington, DC
Bill Christiansen Partner, Seattle
Aaron Nudelman Associate, Seattle
Darren DeStefano Partner, Reston
Related Practices & Industries

Life Sciences Capital Markets Public Companies